Back
Terns Pharmaceuticals, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
TERN
Terns Pharmaceuticals, Inc.
Last Price:
$27.15
Seasonality Move:
24.67%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTerns Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 52.6% based on the past 4 years of stock performance.
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Terns Pharmaceuticals, Inc. Stock Undervalued?The current Terns Pharmaceuticals, Inc. [TERN] share price is $27.49. The Score for TERN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
TERN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Terns Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 52.6% based on the past 4 years of stock performance.
Terns Pharmaceuticals, Inc. Stock Rating
Buy
61
Terns Pharmaceuticals, Inc. (TERN)
is a Buy
Is Terns Pharmaceuticals, Inc. overpriced?
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Terns Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ternspharma.com
52-Week Data
52-Week High:
29.51
52-Week Low:
1.87
Prediction Charts
Market Cap:
2.5B
Price in USD:
27.49
Volume:
3.8M
Beta:
-0.24
Technical Analysis
SMA50:
14.88
SMA100:
10.74
SMA200:
7.04
52-Wk Change:
332.23%
Stock Predictions
-
Is Terns Pharmaceuticals, Inc. stock public?Yes, Terns Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Terns Pharmaceuticals, Inc. stock quote today?The Terns Pharmaceuticals, Inc. stock price is 27.49 USD today.
-
How to buy Terns Pharmaceuticals, Inc. stock online?You can buy Terns Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 20.51 | 22.56 | 23.31 | 20.30 |
| Nov-17 | 22.63 | 25.56 | 26.12 | 22.63 |
| Nov-18 | 25.27 | 27.56 | 27.58 | 25.11 |
| Nov-19 | 27.48 | 27.12 | 28.25 | 26.44 |
| Nov-20 | 27.20 | 26.11 | 28.49 | 26.02 |
| Nov-21 | 25.99 | 26.32 | 26.51 | 25.31 |
| Nov-24 | 27.00 | 28.04 | 28.27 | 26.13 |
| Nov-25 | 28.80 | 29.35 | 29.38 | 27.41 |
| Nov-26 | 29.51 | 28.75 | 29.51 | 28.27 |
| Nov-28 | 28.99 | 28.11 | 29.00 | 28.11 |
| Dec-1 | 27.90 | 27.53 | 28.15 | 26.87 |
| Dec-2 | 27.79 | 25.79 | 27.90 | 25.67 |
| Dec-3 | 25.92 | 27.49 | 27.88 | 25.75 |
| Dec-4 | 27.22 | 27.13 | 28.17 | 26.53 |
Terns Pharmaceuticals, Inc. Earnings
Terns Pharmaceuticals, Inc. Earnings Report: Per Share Terns Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Terns Pharmaceuticals, Inc. Forecast Revenue Growth
Terns Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Terns Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.15 per share.
* Terns Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.